Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Equities researchers at B. Riley issued their FY2023 EPS estimates for Longboard Pharmaceuticals in a report released on Wednesday, April 26th. B. Riley analyst K. Patel anticipates that the company will post earnings of ($2.24) per share for the year. B. Riley currently has a “Buy” rating […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the recipient of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 7,500 shares, a drop of 27.2% from the March 15th total of 10,300 shares. Based on an average trading volume of 33,700 shares, the […]